QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes
Preprint
Abstract
Background: Effective interventions are needed to support co-creation of diabetes care plans that fit patients’ lives. We evaluated the QBSafe agenda-setting kit (14 conversation cards) for its impact on care fit and glycemic control when added to usual primary care. Methods: This single-center, clinician-level cluster-randomized, open-label trial was conducted at a federally qualified health center in New Haven, Connecticut ( ClinicalTrials.gov NCT05553912 ). Clinicians and their patients with type 2 diabetes and HbA1c >8% were randomized 1:1 to usual care with or without QBSafe cards. In the intervention arm, patients selected up to 3 cards highlighting concerns about life with diabetes prior to their visit. Primary outcomes were change at 6 months in care fit (Illness Intrusiveness Ratings Scale, IIRS) and HbA1c, analyzed by intention to treat. Secondary outcomes were treatment burden (Treatment Burden Questionnaire, TBQ) and diabetes distress (Diabetes Distress Scale, DDS), and satisfaction with visits. Results: Between February 2023 and July 2024, 143 participants (mean age 56 years; 61% female; 73% Hispanic; mean HbA1c 10%) were enrolled: 74 received usual care with QBSafe, 69 usual care alone. At 6 months, there were no significant between-arm differences in changes in IIRS (−3.9 [95% CI -10.4, 2.6]), HbA1c (−0.2% [95% CI -0.9, 0.5]), TBQ (1.0 [95% CI -16.6, 18.6]), or DDS (−0.1 [95% CI -0.4, 0.2]). Clinicians reported greater satisfaction when using QBSafe. Patient satisfaction was high and did not differ across arms. Conclusions: QBSafe cards improved clinician satisfaction but did not improve care fit or glycemic control. Future tools should focus on helping clinicians respond effectively to patient-identified challenges.Keywords
This publication has 33 references indexed in Scilit:
- Engagement in Hypertension and Diabetes Clinical Trials at Federally Qualified Health CentersJAMA Network Open, 2025
- Addressing Diabetes Distress in Primary Care: Where Are We Now, and Where Do We Need to Go?Current Diabetes Reports, 2025
- Interrupted opening statements in clinical encounters: A scoping reviewPatient Education and Counseling, 2022
- Beyond hemoglobin A1c: a videographic analysis of conversations about quality of life and treatment burden during clinical encounters for diabetes careEndocrine, 2021
- Bringing Social Context into Diabetes Care: Intervening on Social Risks versus Providing Contextualized CareCurrent Diabetes Reports, 2019
- Eliciting the Patient’s Agenda- Secondary Analysis of Recorded Clinical EncountersJournal of General Internal Medicine, 2018
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial ProtocolsJAMA, 2018
- Using the Illness Intrusiveness Ratings Scale to understand health-related quality of life in chronic diseaseJournal of Psychosomatic Research, 2010
- Validation of Screening Questions for Limited Health Literacy in a Large VA Outpatient PopulationJournal of General Internal Medicine, 2008
- Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial InfarctionJAMA, 2007